NEW YORK, NY / ACCESSWIRE / January 10, 2019 / U.S. markets rose for the fourth consecutive session on Wednesday as minutes released from the Federal Reserve's meeting in December showed the Fed would be “patient” when it came to interest rate hikes. The Dow Jones Industrial Average gained 0.39 percent to close at 23,879.12, while the S&P 500 Index rose 0.41 percent to settle at 2,584.96. The Nasdaq Composite Index surged 0.87 percent to close at 6,957.08.
"All the minutes are doing is confirming what they had already hinted at," said Larry McDonald, editor of The Bear Traps Report. "The Fed speak before the minutes was like a fire hose to calm down the markets."
The Market Edge Initiates Coverage on:
Atossa Genetics Inc.
BioTelemetry's stock jumped 3.50% Wednesday, to close the day at $65.95. The stock recorded a trading volume of 401,124 shares, which was below its three months average volume of 607,616 shares. In the last year, BioTelemetry's shares have traded in a range of 29.85 - 74.73. The share price has gained 120.94% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $62.49 is above its 200-day moving average of $57.55. Shares of the company are trading at a Price to Earnings ratio of 138.55. Shares of BioTelemetry have gained roughly 1.01 percent in the past month and are up 10.43 percent year-to-date.
Access The Market Edge's BioTelemetry, Inc. Research Report:
On Wednesday, shares of Atossa Genetics recorded a trading volume of 18,361,850 shares, which was above the three months average volume of 743,532 shares. The stock ended the day 30.08% higher at $1.60. The share price has fallen 85.02% from its 52
Access The Market Edge's Atossa Genetics Inc. Research Report:
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.